MedTrace Logo

Social Forces to Improve Statin Adherence (Study A)

NCT02018809 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2017-09-14

Study results available
· View outcomes & findings →

Summary

To assess the effectiveness of reporting statin adherence patterns to a Medication Adherence Partner (MAP) in improving the outcome of statin adherence versus usual care as measured by an electronic pill bottle.

Hypothesis: Subjects with a MAP receiving daily adherence feedback will have the highest statin adherence of any arm, as measured by pill bottle data.

Conditions

Interventions

BEHAVIORAL

Medication Adherence Partner

DEVICE

Electronic pill bottle

This device can remotely track medication taking and will be used by subjects to store once-a-day statin medication already prescribed pre-trial.

Sponsors & Collaborators

Principal Investigators

  • Peter P Reese, MD, MSCE · UPenn PSOM

  • Judd B Kessler, PhD · UPenn, Wharton

  • Kevin Volpp, MD, PhD · UPenn, PSOM

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-10-31
Completion
2015-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02018809 on ClinicalTrials.gov